Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endoscann, a new endometrial cell sampler.

E Segadal, O E Iversen

    British Journal of Obstetrics and Gynaecology
    |March 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    The Endoscann device shows promise for screening high-risk individuals for endometrial cancer and investigating postmenopausal bleeding. When combined with clinical assessment, it offers a cost-effective outpatient method for early detection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Medical abortion at 63 to 90 days of gestation.

    Obstetrics and gynecology·2010
    Same author

    Ascitic complement system in ovarian cancer.

    British journal of cancer·2005
    Same author

    The impact of increasing the use of regional anaesthesia for emergency caesarean section.

    European journal of anaesthesiology·2005
    Same author

    Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2004
    Same author

    [Gestagen supplementation to estrogen therapy in climacteric].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
    Same author

    [Mifepristone--a controversial drug with great potential].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002
    Same journal

    Livial: an economic appraisal.

    British journal of obstetrics and gynaecology·2000
    Same journal

    Livial: a review of clinical studies.

    British journal of obstetrics and gynaecology·2000
    Same journal

    Place of birth and shoulder dystocia.

    British journal of obstetrics and gynaecology·1999
    Same journal

    The value of the negative predictive values.

    British journal of obstetrics and gynaecology·1999
    Same journal

    Splenectomy during pregnancy: an option in treatment of autoimmune thrombocytopenic purpura.

    British journal of obstetrics and gynaecology·1999
    Same journal

    Third trimester abortion: is compassion enough?

    British journal of obstetrics and gynaecology·1999
    See all related articles

    Area of Science:

    • Gynecologic Oncology
    • Diagnostic Cytopathology
    • Reproductive Medicine

    Background:

    • Endometrial cancer diagnosis often relies on invasive procedures.
    • Postmenopausal bleeding necessitates accurate and timely investigation.
    • Development of minimally invasive diagnostic tools is crucial for women's health.

    Purpose of the Study:

    • To evaluate the diagnostic accuracy of the Endoscann mechanical sampler compared to traditional histology.
    • To assess the utility of Endoscann for screening high-risk populations and investigating abnormal uterine bleeding.
    • To determine the feasibility of using Endoscann for endometrial staging in infertile women.

    Main Methods:

    • A comparative study involving 200 patients, predominantly postmenopausal women.

    Related Experiment Videos

  • Cytological samples obtained via the Endoscann device were analyzed.
  • Results were compared against conventional histological diagnoses from uterine curettage.

    • Main Results:

    • High diagnostic agreement was observed for cancer (21/23 women) and premalignant disease (2/5 women).
    • Negative cytological results were deemed acceptable only when clinical assessment was also negative.
    • Endoscann provided cell blocks suitable for endometrial staging in infertile patients.

    Conclusions:

    • The Endoscann device is a viable tool for screening high-risk groups for endometrial cancer.
    • It is effective in investigating postmenopausal bleeding, offering a cost-effective outpatient solution.
    • The procedure facilitates endometrial staging, aiding in the management of infertility.